EnChannel Medical has developed a hybrid contact and noncontact mapping system featuring a novel third generation mapping technology that visualizes Action Potential duration. The duration of Action Potential reveals the physiology of both depolarization and repolarization by tracking the electrochemistry of ion channels. The electrochemistry of ion channels represents the true source of the cardiac rhythm.
Therapy: EnChannel’s state-of-the-art PFA ablation system delivers precise focal and signal shot therapies for optimal patient care. Integrated Contact and Non-Contact Mapping: EnChannel’s innovative cardiac mapping system seamlessly integrates contact and non-contact methodologies for comprehensive assessment and improved outcomes. Hybrid Magnetic and Impedance Navigation: EnChannel’s hybrid navigation system precisely tracks both magnetic- and impedance-based catheters. Modern AI-based Algorit
Irvine, CA, USA – July 1, 2025 – EnChannel Medical Ltd., a global leader in cardiac electrophysiology innovation, today announced it has signed a definitive agreement to acquire the AcQMap™ High Resolution Imaging and Mapping platform assets from Acutus Medical Inc....
Founded in 2020 by medical and industry experts in electrophysiology, EnChannel Medical is a pioneering cardiac technology company committed to developing intuitive, safer, and more effective personalized solutions to assist electrophysiologists in treating patients with complex cardiac arrhythmias.
At EnChannel Medical, we’re redefining the boundaries of electrophysiology with our next-generation DePolar™ mapping system and integrated NanoAblate™ PFA platform. Driven by our global mission to enhance the quality-of-life of heart rhythm patients, our discerning technology, paired with our passion for innovation, leads to enduring outcomes.
EnChannel Medical Ltd. (“us”, “we”, or “our”) operates http://www.enchannel.com (the “Site”). This page informs you of our policies regarding the collection, use and disclosure of Personal Information we receive from users of the Site.